1DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus [J]. N Engl J Med, 1993,329(14) ~ 977-986.
2Shichiri M, Kishikawa H, Ohkubo Y, et al. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetes patients [ J ].Diabetes Care, 2000,23 (Suppl 2) : B21 - B29.
3UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [J]. Lancet, 1998, 352(9131 ) : 837-853.
4ACCORD Study Group. Effects of intensive glucose lowering in type 2 diabetes [J]. N Engl J Med,2008,358 (24):2545- 2559.
5ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes [J]. N End J Med.2008.358f24) :2560-2572.
6Duckworth W, Abraira C, Moritz T, et al. VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes [J]. N Engl J Med,2009,360(2) : 129-139.
7Skyler J S, Bergenstal R, Bonow R O, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials : a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association [J]. Circulation ,2009,119(2) :351-357.
8Bonds D E, Miller M E, Bergenstal R M, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study [J ]. BMJ , 2010,340 : b4909.
9Donnelly L A, Morris A D, Frier B M, et al. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study [J]. Diabet Med,2005, 22(6) :749-755.
10I Sophia Z, Anushka P, John C, et al. Severe hypoglycemia and risks of vascular events and death [J]. N Engl Med, 2010,363 (15):1410-1418.
同被引文献13
1Gilpin VL. Review of an article:aspirin for primary preven- tion ofcardiovascular events in people with diabetes. A posi- tion statement of the American Diabetes Association (ADA) ,ascientific statement of the Am erican Heart Asso- ciation (AHA) , and all expert consensus document of the A- merican College of Cardiology Foundation (ACCF) [ J]. Di- abetes Care,2010,33(6) :1395.
